Search

Your search keyword '"Sastry, K. Jagannadha"' showing total 286 results

Search Constraints

Start Over You searched for: Author "Sastry, K. Jagannadha" Remove constraint Author: "Sastry, K. Jagannadha"
286 results on '"Sastry, K. Jagannadha"'

Search Results

1. Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring

7. Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation

8. Immunity from NK Cell Subsets Is Important for Vaccine-Mediated Protection in HPV+ Cancers.

9. Supplemental Tables from Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers

10. Data from Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers

11. Supplemental Table Legends from Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers

12. Supplementary Data from Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers

13. Table S3 from Effect of Antibiotics on Gut and Vaginal Microbiomes Associated with Cervical Cancer Development in Mice

14. Data from Effect of Antibiotics on Gut and Vaginal Microbiomes Associated with Cervical Cancer Development in Mice

15. Supplementary Figure Legends from Effect of Antibiotics on Gut and Vaginal Microbiomes Associated with Cervical Cancer Development in Mice

16. Supplementary Figures from Effect of Antibiotics on Gut and Vaginal Microbiomes Associated with Cervical Cancer Development in Mice

17. Supplementary Table Legends from Effect of Antibiotics on Gut and Vaginal Microbiomes Associated with Cervical Cancer Development in Mice

21. Supplementary Digs. S7 and S8 from Mucosal HPV E6/E7 Peptide Vaccination in Combination with Immune Checkpoint Modulation Induces Regression of HPV+ Oral Cancers

26. Immune environment and antigen specificity of the T cell receptor repertoire of malignant ascites in ovarian cancer

30. Cancer-associated Lactobacillus iners are genetically distinct and associated with chemoradiation resistance in cervical cancer

31. Mucosal Vaccination With Recombinant Tm-WAP49 Protein Induces Protective Humoral and Cellular Immunity Against Experimental Trichuriasis in AKR Mice

32. Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers

34. Tumor-Resident  Lactobacillus iners Confers Chemoradiation Resistance in Cervical Cancer Patients Through Acquired Metabolic Functions

35. TIGIT as a therapeutic target of HPV-positive head and neck squamous cell carcinomas

37. Antiviral Effects of Oleandrin

38. Preventive Efficacy of a Tenofovir Alafenamide Fumarate Nanofluidic Implant in SHIV‐Challenged Nonhuman Primates (Adv. Therap. 3/2021)

40. Preventive Efficacy of a Tenofovir Alafenamide Fumarate Nanofluidic Implant in SHIV‐Challenged Nonhuman Primates

41. Effect of Antibiotics on Gut and Vaginal Microbiomes Associated with Cervical Cancer Development in Mice

46. Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic Implant

49. Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation

50. Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV-challenged nonhuman primates

Catalog

Books, media, physical & digital resources